NewAmsterdam Pharma Company N.V.NAMSNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank40
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P40
Within normal range
vs 3Y Ago
-0.3x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-28.02%
20243.65%
2023-5043.86%
202289.83%
2021-427.39%
20200.00%